Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1987 Jul;24(1):69–75. doi: 10.1111/j.1365-2125.1987.tb03138.x

Pharmacokinetics and metabolism of salbutamol in premature labour.

M J Hutchings, J D Paull, E Wilson-Evered, D J Morgan
PMCID: PMC1386282  PMID: 3620288

Abstract

1 The pharmacokinetics of salbutamol and its sulphate conjugate were examined during intravenous and steady-state oral administration in nine patients receiving the drug for the prevention or treatment of premature labour. 2 Uterine contractions were inhibited by plasma salbutamol concentrations in the range 8-33 ng ml-1 in six of the seven patients who were receiving intravenous drug. 3 By comparison with our previous study in a control group of healthy males and nonpregnant females, the total clearance of salbutamol in premature labour (501; s.d. 185 ml min-1) was similar to that in the control group (480; s.d. 123 ml min-1). Renal salbutamol clearance (208; s.d. 51 ml min-1), however, was significantly less than that in the control group (283; s.d. 51 ml min-1). 4 The systemic availability (n = 3), urinary recovery of unchanged oral salbutamol and area under the plasma curve during the oral dosage interval (n = 5) were all only slightly lower (10-20%) than control values, suggesting slightly lower oral absorption. 5 Formation and elimination of the sulphate conjugate were similar to those observed in control subjects suggesting that first-pass sulphation in the gut wall is unchanged in pregnancy. Overall there were only minor differences in salbutamol pharmacokinetics between control subjects and patients in premature labour.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boxenbaum H. G., Riegelman S., Elashoff R. M. Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm. 1974 Apr;2(2):123–148. doi: 10.1007/BF01061504. [DOI] [PubMed] [Google Scholar]
  2. Caritis S. N. Treatment of preterm labour. A review of the therapeutic options. Drugs. 1983 Sep;26(3):243–261. doi: 10.2165/00003495-198326030-00005. [DOI] [PubMed] [Google Scholar]
  3. Chiba K., Ishizaki T., Tabuchi T., Wagatsuma T., Nakazawa Y. Antipyrine disposition in relation to lowered anticonvulsant plasma level during pregnancy. Obstet Gynecol. 1982 Nov;60(5):620–626. [PubMed] [Google Scholar]
  4. Chow A. W., Jewesson P. J. Pharmacokinetics and safety of antimicrobial agents during pregnancy. Rev Infect Dis. 1985 May-Jun;7(3):287–313. doi: 10.1093/clinids/7.3.287. [DOI] [PubMed] [Google Scholar]
  5. Eggers T. R., Doyle L. W., Pepperell R. J. Premature labour. Med J Aust. 1979 Mar 24;1(6):213–216. [PubMed] [Google Scholar]
  6. Evans M. E., Walker S. R., Brittain R. T., Paterson J. W. The metabolism of salbutamol in man. Xenobiotica. 1973 Feb;3(2):113–120. doi: 10.3109/00498257309151506. [DOI] [PubMed] [Google Scholar]
  7. Hastwell G. B., Halloway C. P., Taylor T. L. A study of 208 patients in premature labour treated with orally administered salbutamol. Med J Aust. 1978 May 6;1(9):465–469. doi: 10.5694/j.1326-5377.1978.tb112559.x. [DOI] [PubMed] [Google Scholar]
  8. Haukkamaa M., Gummerus M., Kleimola T. Serum salbutamol concentrations during oral and intravenous treatment in pregnant women. Br J Obstet Gynaecol. 1985 Dec;92(12):1230–1233. doi: 10.1111/j.1471-0528.1985.tb04867.x. [DOI] [PubMed] [Google Scholar]
  9. Hutchings M. J., Paull J. D., Morgan D. J. Determination of salbutamol in plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1983 Oct 14;277:423–426. doi: 10.1016/s0378-4347(00)84870-7. [DOI] [PubMed] [Google Scholar]
  10. Knutti R., Rothweiler H., Schlatter C. Effect of pregnancy on the pharmacokinetics of caffeine. Eur J Clin Pharmacol. 1981;21(2):121–126. doi: 10.1007/BF00637512. [DOI] [PubMed] [Google Scholar]
  11. Krauer B., Krauer F., Hytten F. E. Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacol Ther. 1980;10(2):301–328. doi: 10.1016/0163-7258(80)90085-6. [DOI] [PubMed] [Google Scholar]
  12. Lander C. M., Smith M. T., Chalk J. B., de Wytt C., Symoniw P., Livingstone I., Eadie M. J. Bioavailability and pharmacokinetics of phenytoin during pregnancy. Eur J Clin Pharmacol. 1984;27(1):105–110. [PubMed] [Google Scholar]
  13. Lin C., Li Y., McGlotten J., Morton J. B., Symchowicz S. Isolation and identification of the major metabolite of albuterol in human urine. Drug Metab Dispos. 1977 May-Jun;5(3):234–238. [PubMed] [Google Scholar]
  14. Luxford A. M., Kellaway G. S. Pharmacokinetics of digoxin in pregnancy. Eur J Clin Pharmacol. 1983;25(1):117–121. doi: 10.1007/BF00544027. [DOI] [PubMed] [Google Scholar]
  15. Martin L. E., Hobson J. C., Page J. A., Harrison C. Metabolic studies of Salbutanol-3H: a new bronchodilator, in rat, rabbit, dog and man. Eur J Pharmacol. 1971 Apr;14(2):183–199. doi: 10.1016/0014-2999(71)90211-1. [DOI] [PubMed] [Google Scholar]
  16. Mather L. E., Ringrose R. L., Austin K. L. Determination of pharmacokinetic constants after multiple infusions of drugs. Eur J Clin Pharmacol. 1982 Oct;23(4):353–358. doi: 10.1007/BF00613620. [DOI] [PubMed] [Google Scholar]
  17. Morgan D. J., Paull J. D., Richmond B. H., Wilson-Evered E., Ziccone S. P. Pharmacokinetics of intravenous and oral salbutamol and its sulphate conjugate. Br J Clin Pharmacol. 1986 Nov;22(5):587–593. doi: 10.1111/j.1365-2125.1986.tb02939.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. O'Hare M. F., Kinney C. D., Murnaghan G. A., McDevitt D. G. Pharmacokinetics of propranolol during pregnancy. Eur J Clin Pharmacol. 1984;27(5):583–587. doi: 10.1007/BF00556896. [DOI] [PubMed] [Google Scholar]
  19. Paulin F., Csömör S. Die Veränderungen der Ostriolausscheidung im Harn und der Nierenfunktion während Partusisten-Infusion. Z Geburtshilfe Perinatol. 1982 Oct;186(5):244–248. [PubMed] [Google Scholar]
  20. Pedersen P. V. Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm. 1977 Oct;5(5):513–531. doi: 10.1007/BF01061732. [DOI] [PubMed] [Google Scholar]
  21. Pincus R. Salbutamol infusion for premature labour--the Australian trials experience. Aust N Z J Obstet Gynaecol. 1981 Feb;21(1):1–4. doi: 10.1111/j.1479-828x.1981.tb00113.x. [DOI] [PubMed] [Google Scholar]
  22. Walker S. R., Evans M. E., Richards A. J., Paterson J. W. The clinical pharmacology of oral and inhaled salbutamol. Clin Pharmacol Ther. 1972 Nov-Dec;13(6):861–867. doi: 10.1002/cpt1972136861. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES